Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,400,060 papers from all fields of science
Search
Sign In
Create Free Account
Induction procedure
Known as:
induction
, inductions
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Effects of thiopentone, propofol and alfaxalone on laryngeal motion during oral laryngoscopy in healthy dogs.
T. Smalle
,
M. Hartman
,
L. Bester
,
Roxanne K. Buck
,
G. Fosgate
,
G. Zeiler
Veterinary Anaesthesia and Analgesia
2017
Corpus ID: 205574448
2017
2017
Induction of human cytochrome P450 3A enzymes in cultured placental cells by thalidomide and relevance to bioactivation and toxicity.
N. Murayama
,
Y. Kazuki
,
+5 authors
H. Yamazaki
Journal of Toxicological Sciences
2017
Corpus ID: 7229790
Evidence has been presented for auto-induced human cytochrome P450 3A enzyme involvement in the teratogenicity and clinical…
Expand
2016
2016
Characterization of ligand-dependent activation of bovine and pig constitutive androstane (CAR) and pregnane X receptors (PXR) with interspecies comparisons
Jenni Küblbeck
,
V. Zancanella
,
+5 authors
M. Giantin
Xenobiotica; the fate of foreign compounds in…
2016
Corpus ID: 9614160
Abstract 1. Nuclear receptors CAR (NR1I3) and PXR (NR1I2) are major ligand-activated transcriptional regulators of xenobiotic…
Expand
2015
2015
Induction of CYP3A by morroniside in rats.
S. Xiong
,
Jinglai Li
,
Wenpeng Zhang
,
Xiaoying Wang
,
Zhen-qing Zhang
Journal of Pharmacological Sciences
2015
Corpus ID: 10675304
2014
2014
Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in…
F. Kocher
,
A. Pircher
,
+8 authors
R. Greil
Lung Cancer
2014
Corpus ID: 206752159
2014
2014
Risk of serious opportunistic infections after solid organ transplantation: interleukin-2 receptor antagonists versus polyclonal antibodies. A meta-analysis
A. Kalil
,
M. Florescu
,
+5 authors
D. Florescu
Expert Review of Anti-Infective Therapy
2014
Corpus ID: 5487127
Background: We aimed to evaluate and quantify the risk of serious opportunistic infections after induction with polyclonal…
Expand
2008
2008
Incorporation of bevacizumab (B) and erlotinib (Er) with induction (Ind) and concurrent (Conc) carboplatin (Cb)/paclitaxel (P) and 74 Gy of thoracic radiotherapy in stage III non-small cell lung…
M. Socinski
,
T. Stinchcombe
,
+7 authors
D. Morris
Journal of Clinical Oncology
2008
Corpus ID: 35295236
7528 Background: Therapies directed at both the epidermal growth factor receptor (EGFR) and the vascular endothelial growth…
Expand
2006
2006
Induction (ICT) or consolidation chemotherapy (CT) with cisplatin (C) and paclitaxel (P) plus concurrent chemo-radiation (CT/TRT) with cisplatin and vinorelbine (V) for unresectable non-small cell…
P. Fournel
,
A. Vergnenègre
,
+7 authors
I. Martel-Lafay
Journal of Clinical Oncology
2006
Corpus ID: 33619015
7048 Background: Concurrent CT/TRT is the standard treatment for unresectable stage III NSCLC, but the optimal sequencing of TRT…
Expand
1993
1993
Photosynthetic induction times in shade-tolerant species with long and short-lived leaves
T. A. Kursar
,
P. D. Coley
Oecologia
1993
Corpus ID: 8382562
In the understory of a tropical rainforest, light flecks can contribute 10–80% of the total light flux. We investigated the…
Expand
Review
1993
Review
1993
Dissecting Wnt signalling pathways and Wnt-sensitive developmental processes through transient misexpression analyses in embryos of Xenopus laevis.
R. Moon
,
J. Christian
,
+6 authors
G. Kelly
Development
1993
Corpus ID: 42119159
We review evidence that Xenopus Wnts (Xwnts) have activities consistent with their hypothesized roles as secreted signalling…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE